Gapping up :
In reaction to strong earnings/guidance:
ACY +46.9% (thinly traded),
BCRX +34.9%,
FSYS +17.6%,
EBS +16.9%,
ARP +15.6% (light volume),
LMIA +15.3%,
MNTG +11.9%,
SAH +11.8%,
EXEL +10.7% (also Exelixis and Boehringer Ingelheim enter into collaboration for development of S1P1 receptor agonists in the field of autoimmune diseases),
HTGC +10.4%,
TC +8.0%,
VRSN +7.9% (also upgraded to Outperform at Oppenheimer),
HANS +7.7%,
DXPE +7.6%,
NVAX +6.7ac%,
AIRM +6.5% (light volume),
IPI +6.4%,
EP +5.6%,
SAPE +5.3%,
AIG +4.6%,
ATVI +4.5% (also upgraded to Buy at BofA/Merrill),
AGO +4.2%,
WTW +4.0%,
THOR +3.6%,
SPF +3.1%,
PCR +3.1%,
MCD +3.0%,
NILE +1.0%...
M&A news:
VNUS +34.6% (announces that it has reached agreement to be acquired by Covidien for $29.00 per share)...
Select financials showing strength:
FITB +21.7% (to strengthen Tier 1 common equity by $1.1 bln; also upgraded to Outperform at Bernstein),
HBAN +15.7%,
FIG +15.1%,
RBS +15.0% (surged 13.5% in overseas trading),
C +11.5% (to expand public exchange offers by $5.5 bln to meet U.S. Government Stress Test Requirements),
RF +10.9% (announces Supervisory Capital Assessment Program Findings; to increase common equity by $2.5 bln),
BAC +9.4% (stress test shows that in order to weather two years of the most severe economic circumstance, it would need to increase Tier 1 common capital by $33.9 bln; also upgraded to Mkt Perform from Underperform at Wachovia),
KEY +9.1% (overall capital sufficient; to lift common equity by $1.8 bln),
STT +8.5% (passes Stress Test with substantial capital buffer; also upgraded to Buy at BofA/Merrill),
CIT +8.1%,
ING +7.2%,
USB +7.2% (The Federal Reserve indicates "no need" for additional capital buffer),
DB +4.8%,
BBT +4.7% (capital levels exceed stress test requirements; don't need to raise capital),
BK +4.4% (says stress test results are strong; company not required to raise additional capital),
JPM +4.3% (announces that government concludes no need for JPMorgan Chase to raise additional capital),
AZ +4.3%,
BX +4.1%,
AXP +3.7% (Stress Test finds "no capital need"; files for permission to repay govt funds),
COF +3.4% (says passes government stress test),
PNC +3.4% (announces that it plans to satisfy the requirement to increase common shareholders' equity by $600 mln),
MET +3.0% (has adequate capital to sustain a further deterioration in the economy),
STI +2.9% (responds to U.S. Government's stress test report),
GS +2.8% (Federal Reserve determines Goldman Sachs does not require further capital; will soon repay TARP investment), ... Select oil/gas names trading higher:
E +3.8%,
WFT +3.8%,
TOT +3.0%,
OXY +2.5%,
SLB +2.3%...
Select metals/mining names showing strength:
ACH +10.8%,
MT +4.7%,
GOLD +3.6% (upgraded to Buy at Citigroup)...
Select shipping names trading higher:
NM +12.9%,
EGLE +5.1%..
Other news:
CYTX +27.2% (the co and GE Healthcare announce an agreement by which GE Healthcare will commercialize Cytori's StemSource technology),
CDNS +19.0% (continued momentum from yesterday's jump),
ONNN +11.2% (Cramer makes positive comments on MadMoney),
BRCD +9.5% (still checking)...
Analyst comments:
AXL +29.1% (upgraded to Buy at Deutsche Bank),
SI +3.0% (upgraded to Buy at RBS).